Phenomix Investigational Site 112 — Greenville, South Carolina

Phenomix Investigational Site 112 is a clinical research site located in Greenville, South Carolina, United States.

Crixeo Health Trust Score: 43/100 (POOR). This profile has not yet been claimed by the site owner.

Phenomix Investigational Site 112 has participated in 2 clinical trials.

Therapeutic areas: Type 2 Diabetes Mellitus.

Sponsors: Phenomix.

Sponsor Feasibility Report

Trust Score: 43/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Phenomix Investigational Site 112?

Phenomix Investigational Site 112 has a Crixeo Trust Score of 43/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Phenomix Investigational Site 112 conducted?

Phenomix Investigational Site 112 has 2 clinical trials on record. Their work covers Type 2 Diabetes Mellitus.

Is Phenomix Investigational Site 112 accredited by Crixeo Health?

Phenomix Investigational Site 112 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Phenomix Investigational Site 112?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.